Cas:74839-84-2 (2r,3r)-(+)-bis(diphenylphosphino)butane manufacturer & supplier

Chemical Name:(2r,3r)-(+)-bis(diphenylphosphino)butane

CAS.NO:74839-84-2

Synonyms:(2R,3R)-2,3-Bis(diphenylphosphino)butan;bis(diphenylphosphino)-1,2-dimethylethane;(R,R)-2,3-bis(diphenylphosphanyl)butane;(-)-(2S,3S)-bis(diphenylphosphino)butane;R,R-Chiraphos;(2R,3R)-(+)-Bis(diphenylphosphino)butane (R,R)-CHIRAPHOS;(2R,3R)-(+)-2,3-BIS(DIPHENYL PHOSPHINO)BUTANE

Molecular Formula:C₂₈H₂₈P₂

Molecular Weight:426.46900

HS Code:29310099

Physical and Chemical Properties:

Melting point:104-109ºC

Boiling point:529.2ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:27.18000

Exact Mass:426.16700

LogP:6.02920

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2R,3R)-2,3-Bis(diphenylphosphino)butan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R,3R)-(+)-2,3-BIS(DIPHENYL PHOSPHINO)BUTANE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R,3R)-2,3-Bis(diphenylphosphino)butan Use and application,bis(diphenylphosphino)-1,2-dimethylethane technical grade,usp/ep/jp grade.

Related News: In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers. (5R,11aR)-3,11a-di((S)-sec-butyl)-9-(2,3-diacetoxy-4′,5,6-trihydroxy-[1,1′-biphenyl]-4-yl)-2,4-dihydroxy-1-oxo-1,11a-dihydrobenzo[e]pyrazino[1,2-b][1,4,2]dioxazine 5(2H)-oxide manufacturers In our phase 2 program, with partners BStrong, The Grant Cardone Foundation (https://grantcardonefoundation.com) and The Alexander Team (https://thealexanderteam.com), we supplied short term condo apartment units for 1-6 months underwritten by local hoteliers. 3-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-6-[(Z)-2-(5-nitro-furan-2-yl)-vinyl]-pyridazine 1-oxide suppliers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. (2S,4R)-4-hydroxy-N-methyl-1-pivaloylpyrrolidine-2-carboxamide vendor & factory.